HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study

BACKGROUND: As a simplification strategy for treatment-experienced HIV-infected patients who have achieved virologic suppression on a multi-drug, multi-class antiretroviral regimen, the aim of this study was to evaluate the safety, efficacy, and pharmacokinetics of once-daily elvitegravir/cobicistat...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Marianne, Ganase, Bruce, Watson, Birgit, Harrigan, P. Richard, Montaner, Julio S. G., Hull, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669010/
https://www.ncbi.nlm.nih.gov/pubmed/29096670
http://dx.doi.org/10.1186/s12981-017-0185-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669010/
https://www.ncbi.nlm.nih.gov/pubmed/29096670
http://dx.doi.org/10.1186/s12981-017-0185-4

Ejemplares similares